Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat ® Soft Mist™ Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma

By Vincken W.  

Clinical Drug Investigation, Vol. 24, Iss. 1, 2004-01 ,pp. : 17-28

Adis International

Access to resources Recommend Favorite

Formoterol Monotherapy Compared with Combined Ipratropium Bromide plus Fenoterol in the Treatment of Chronic Obstructive Pulmonary Disease

By Konermann M.  

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 235-242

Adis International

Access to resources Recommend Favorite

One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease

By Brazinsky S.A.  

Clinical Drug Investigation, Vol. 23, Iss. 3, 2003-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite

Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease

By Gordon Joshiah   Panos Ralph J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

Lung and oropharyngeal depositions of fenoterol hydrobromide delivered from the prototype III hand-held multidose Respimat nebuliser

By Steed K.P.   Towse L.J.   Freund B.   Newman S.P.  

European Journal of Pharmaceutical Sciences, Vol. 5, Iss. 2, 1997-03 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite